Sign in

Esther van Kleef

@esthervk.bsky.social
759 followers 423 following 58 posts

Infectious disease epidemiologists working on AMR, modelling and ID surveillance @WHO and UoOxford. Alone we move fast, together we move mountains

PostsRepliesMedia
Esther van Kleef @esthervk.bsky.social · 08/10/2026
#Episky
000
Esther van Kleef @esthervk.bsky.social · 08/10/2026
Benefiting from brilliant expertise from Zvitambo, @oxprimarycare.bsky.social @ndm.ox.ac.uk @modmedmicro.bsky.social @liverpooluni.bsky.social @lshtm.bsky.social @qmulfmd.bsky.social @ukceh.bsky.social with @nstoesser.bsky.social Koen Pouwels, Andrew Prendergast, Robert Ntozini and many others!
020
Esther van Kleef @esthervk.bsky.social · 08/10/2026
At the same time identifying key drivers of community-level AMR exposure, and generating causal evidence on what works, for whom, and under what conditions. (4/4)
110
Esther van Kleef @esthervk.bsky.social · 08/10/2026
Taking a One Health perspective, we’ll co-design and test animal-sensitive and climate-resilient WASH solutions that address interconnected human–animal–water systems, while remaining contextualised, yet scalable, low-cost and sustainable. (3/4)
110
Esther van Kleef @esthervk.bsky.social · 08/10/2026
Aiming to be genuinly transdisciplinary, we’ll go beyond ‘traditional’ Water, Sanitation and Hygiene (WASH) approaches which focus largely on human faecal–oral transmission and individual behavioural change. (2/4)
110
Esther van Kleef @esthervk.bsky.social · 08/10/2026
Really excited and grateful to get started together with co-lead Zvitambo, and others, on tackling environmental AMR pathways in rural, sub-Saharan settings through our recently funded UKRI CLEAN-AMR study tinyurl.com/2jvtyhuw within this scheme www.ukri.org/opportunity/.... (1/4)
221
Reposted by Esther van Kleef
Centre for Tropical Medicine and Global Health @tropicalmedicine.ox.ac.uk · 07/07/2026
#ResearchHighlight from Cherry Lim @cghr.ox.ac.uk   The burden of antimicrobial-resistant bacterial infections: a causal perspective Read more 👉 ndm.ac/tropmed-res-hi Full publication 👉 www.nature.com/articles/s41...
166
Esther van Kleef @esthervk.bsky.social · 10/08/2026
Another huge thanks to colleagues at CRUN / URCN, @ox.ac.uk, @itmantwerp.bsky.social @uantwerpen.be, and many dedicated field, lab, and community partners.
010
Esther van Kleef @esthervk.bsky.social · 10/08/2026
Perhaps more importantly, strong seasonality and links with sanitation suggested that the mitigation of AMR burden in low-resource sSA settings will have to involve targeting #environmental transmission pathways alongside #antibiotic use.
130
Esther van Kleef @esthervk.bsky.social · 10/08/2026
Most stewardship interventions stop there....With repeated stool sampling, we went further, quantifying whether the intervention also changed acquisition of resistant bacteria within households and communities. Our findings support a beneficial effect on ESBL E. coli acquisition in the short term.
110
Esther van Kleef @esthervk.bsky.social · 10/08/2026
Our low-cost, co-created intervention targeted #antibiotic use and #WASH across communities and formal and informal medicine providers. The earlier companion paper published in @thelancetinfdis.bsky.social showed clear intervention effects on antibiotic dispensing (listen here shorturl.at/lGDud).
shorturl.at
Brecht Ingelbeen and Daniel Valia on a community-based antimicrobial stewardship intervention in Burkina Faso and DRC
Podcast Episode · The Lancet Infectious Diseases in conversation with · June 15 · 27m
100
Esther van Kleef @esthervk.bsky.social · 10/08/2026
We found high levels of ESBL-producing E. coli carriage and acquisition among ~1200 community members - providing rare longitudinal data on community and household AMR dynamics in a high-burden sub-Saharan African setting.
shorturl.at
Brecht Ingelbeen and Daniel Valia on a community-based antimicrobial stewardship intervention in Burkina Faso and DRC
Podcast Episode · The Lancet Infectious Diseases in conversation with · June 15 · 27m
110
Esther van Kleef @esthervk.bsky.social · 10/08/2026
Changing antibiotic dispensing of #AMR is one thing. But does it actually reduce the problem? Our new paper, part II of the CABU EICO study, is now out! #IDSky #ClinMicro #OpenAccess #OA @ndm.ox.ac.uk @itmantwerp.bsky.social @oxprimarycare.bsky.social
186
Esther van Kleef @esthervk.bsky.social · 26/03/2026
Looking forward to work with great partners to share our results in the coming year! CRUN / URCN (Burkina Faso), @kemriwellcome.bsky.social (Kenya),@itmantwerp.bsky.social, @medsci.ox.ac.uk, @umcutrecht.bsky.social,Basel (UKBB).,@nstoesser.bsky.social @ingelbeen.bsky.social @bugwonk.bsky.social(3/3)
000
Esther van Kleef @esthervk.bsky.social · 26/03/2026
...Combining metagenomic output from environmental and human reservoirs with modelling, we aim to develop sentinel surveillance that can: • Guide empiric prescribing where microbiology is absent; • Identify/monitor community-level AMR exposure risks in rural, low-resource settings. (2/3)
100
Esther van Kleef @esthervk.bsky.social · 26/03/2026
tinyurl.com/yzjuadpu Our ALARUM protocol is now out #JPIAMR! How do we make metagenomics and One Health actionable - especially in LMICs, where microbiology and sewage surveillance are not straightforward? ALARUM aims to tackle this using innovative pooled metagenomic sequencing...(1/3)
234
Esther van Kleef @esthervk.bsky.social · 19/03/2026
Using pooled-sampling, ALARUM aims to develop an affordable and scalable One Health metagenomics surveillance strategy that can: 1) Guide empiric prescribing where microbiology is absent 2) Identify and monitor community-level AMR exposure risks in rural, low-resource settings.
010
Reposted by Esther van Kleef
gram-oxford.bsky.social @gram-oxford.bsky.social · 20/01/2026
AMR researchers and professionals, please join the #GRAMproject on 29th Jan to learn more about key tools and resources, including MICROBE, GLASS, the AMR R package, and the AMR data repository! Register below. Story: bit.ly/4pJuBAD
bit.ly
GRAM to host 29th January webinar on AMR tools and resources
015
Esther van Kleef @esthervk.bsky.social · 25/12/2025
#IDsky #Episky #Medsky
100
Esther van Kleef @esthervk.bsky.social · 25/12/2025
Missed the launch of the latest #WHO_GLASS report? Here a brief newsdesk summary @thelancetinfdis.bsky.social highlighting the progress made in GLASS participation, and why increased investment in AMR, incl. improved access to basic microbiology, remains pressing.. www.thelancet.com/journals/lan...
thelancet.com
WHO publishes update on global antibiotic resistance
A new report from WHO highlights the increasing threat of antibiotic resistance, particularly in regions with limited surveillance and access to antibiotics. Timothy Jesudason reports.
100
Esther van Kleef @esthervk.bsky.social · 20/12/2025
#EpiSky #IDSky
000
Esther van Kleef @esthervk.bsky.social · 20/12/2025
I should add: many AMR/stewardship interventions don't measure microbiological outcomes such as we did. By measuring microbiological outcomes using longitudinal stool sampling, we provided rare insight into AMR transmission dynamics in rural sub-Saharan Africa #Episky #IDsky
020
Esther van Kleef @esthervk.bsky.social · 20/12/2025
Huge thanks to an amazing collaborative team R. Aizouk, Y. Sibidou, D. Valia, @ingelbeen.bsky.social , L. Campbell, JS. Kouanda, A. Welgo, PM Diagne, B. Riems, L. Hardy, E.Wouters, M. Meudec, M. van der Sande, H. Tinto, @bugwonk.bsky.social, and the wider CABU-EICO study team!
010
Esther van Kleef @esthervk.bsky.social · 20/12/2025
This work comes jointly with lnkd.in/em3e-RAg. The protocol, surveys and model codes can all be found here lnkd.in/e5aBTrSX.
lnkd.in
Effect of a community-based behavioural intervention bundle to improve antibiotic use and patient management in Burkina Faso and DR Congo: a cluster randomized controlled trial
Background Limited AMR awareness, limited diagnostic capacity, and frequent self-medication contribute to incorrect antibiotic use in LMIC. We evaluated a community-based intervention to improve antib...
100
Esther van Kleef @esthervk.bsky.social · 20/12/2025
So: Low-cost, non-technology community interventions can reduce AMR. But..this also highlights that in high-burden rural AMR settings, in addition to antibiotic use, tackling environmental transmission is key!
100
Esther van Kleef @esthervk.bsky.social · 20/12/2025
We found: 1️⃣ High baseline AMR (ESBL-E. coli) carriage (~50%) 2️⃣ >10 times higher household-transmission than in HIC 3️⃣Antibiotic dispensing fell by >50%, with low baseline healthcare seeking and ab use 4️⃣ ~20% reduction in ESBL-E acquisition after 6 months 5️⃣Seasonal acquisition, peaking in wet season
100
Esther van Kleef @esthervk.bsky.social · 20/12/2025
New PREPRINT! tinyurl.com/yynzevrh Thanks to a true transdisciplinary collaboration, we developed and evaluated a low-cost community #AMR intervention set in rural Burkina Faso and DRCongo. Combining #WHO #AWaRe–based feedback/training (medicine providers) and AMR awareness campaigns (community).
255
Esther van Kleef @esthervk.bsky.social · 27/10/2025
Alternative way of science communication: @worldpop-uos.bsky.social made a podcast of our recent work on modelling for pandemic decision making in @eurosurveillance.org! Click on the link below to listen 👇
051
Esther van Kleef @esthervk.bsky.social · 23/10/2025
@mugkraemer.bsky.social
000
Esther van Kleef @esthervk.bsky.social · 23/10/2025
We should find sustainable mechanisms for these infrastructures and collaborations to stay, which may include funding models that bring together public, non-profit, and private-sector partners. More to read in the full text. Thanks to all collaborators and funders @ec.europa.eu
001
Esther van Kleef @esthervk.bsky.social · 23/10/2025
@chpoletto.bsky.social @sdellicour.bsky.social @mariusgilbert.bsky.social @lauradidomenico.bsky.social @eonore.bsky.social Wim V. Bortel, Elena Arsevska, Vittoria Colizza, L. Busani, Shengjie Lai, P. Lemey, S. Merler, Z. Milosavljevic, A Rizzoli, D. Simic, Andy Tatem, M. Teisseire, William Wint
110
Esther van Kleef @esthervk.bsky.social · 23/10/2025
Intending to move beyond our “prepare-for-the-previous-pandemic” bias, this work highlights, among other findings, how the collaborative platforms and research consortia that emerged during COVID-19 laid the groundwork for new data and modelling ecosystems.
111
Esther van Kleef @esthervk.bsky.social · 23/10/2025
However, systematic, quantitative analyses remain rare; for COVID-19 but also for previous PH threats. These reflections are easy to set aside once urgency fades and fatigue sets in, especially in an academic world that rewards moving on quickly and governments driven by short political cycles.
101
Esther van Kleef @esthervk.bsky.social · 23/10/2025
Our main aim with this publication was to help preserve a collective memory of how data were generated, shared, and interpreted through modelling during the COVID-19 pandemic. Many opinions and reflections have been written.
101
Esther van Kleef @esthervk.bsky.social · 23/10/2025
Really great to see that our paper is now officially published in the latest #Eurosurveillance. As it was accepted with only minor edits, this earlier post still captures the key messages: tiny.cc/036u001.
172
Reposted by Esther van Kleef
Emily Moin @emilymoin.com · 10/10/2025
I am open to the idea that there are people who don't have and don't want to gain the skills to engage directly with their data but every single day that I do I learn the answer to a question you'd never even think to ask unless you were personally staring into the abyss of an uncleaned dataset.
58011
Esther van Kleef @esthervk.bsky.social · 09/10/2025
This has been a huge undertaking and a great leap forward in reporting global AMR surveillance data. For the first time, country, and regional-level data are supported my Bayesian modelling that allow for better comparison of resistance rates between countries/ regions and trends over time @who.int
010
Esther van Kleef @esthervk.bsky.social · 09/10/2025
Coming Monday 13 October, WHO will launch the latest Global antibiotic resistance surveillance report. Don't miss it, register here! www.who.int/news-room/ev...
111
Reposted by Esther van Kleef
Gwen Knight @gmknght.bsky.social · 10/06/2025
Very excited for this event on the 9th July! It's part of our #AMR short course but open to everyone as it's online. Do join in and here what the amazing Prof Dame Sally Davies has to stay on the current status of global action on #AMR! @lshtmamrcentre.bsky.social
0179
Reposted by Esther van Kleef
Quentin Leclerc @quentinlclrc.bsky.social · 19/06/2025
We're recruiting a postdoc in our lab @mesurs-cnam.bsky.social (Paris) to work on epidemic modelling over healthcare networks, as part of the EU project ARCANE ! 💻🦠 Start date between 09/25-01/26, 2y contract Interested in AMR, healthcare-related research & mathematical modelling? Find out more! ⬇️
iddjobs.org
IDDjobs — Postdoctoral position in epidemic modelling over healthcare networks — Conservatoire national des Arts et Métiers
Find infectious disease dynamics modelling jobs, studentships, and fellowships.
054
Esther van Kleef @esthervk.bsky.social · 11/06/2025
Great ID modelling opportunity to aim for real impact on mitigating and monitoring AMR in sub-Saharan Africa. You'll work closely with us @ox.ac.uk, and Oxford’s Modernising Medical Microbiology group, as well as collaborators at CRUN (Burkina Faso) and KWRTP-KEMRI (Kenya). tinyurl.com/mry25kxe
tinyurl.com
Epidemiologist
Epidemiologist for modelling AMR transmission in LMICMore than 500 staff members at the Institute of Tropical Medicine (ITM) contribute e...
0119
Esther van Kleef @esthervk.bsky.social · 04/05/2025
Certainly! And sharing the knowledge here in England whenever I can now stroopwafels are almost as much an export product as Gouda cheese…
020
Esther van Kleef @esthervk.bsky.social · 29/04/2025
Not sure what happened but this link should work, thanks Quentin! www.who.int/publications...
who.int
Global Antimicrobial Resistance and Use Surveillance System (‎GLASS)‎ report: antibiotic use data for 2022
This Global Antimicrobial Resistance and Use Surveillance System (GLASS) report describes global progress in GLASS-AMU surveillance and antibiotic use in 2022, reported by 60 countries. It supplements...
010
Esther van Kleef @esthervk.bsky.social · 29/04/2025
The first preview was also presented at ESCMID global see tinyurl.com/4sh5v3hf. Combined these reports provide valuable new insights to enhance country-level use of GLASS data to help inform local, national, and regional AMR strategies World Health Organization #UNGA.
000
Esther van Kleef @esthervk.bsky.social · 29/04/2025
The GLASS report on antimicrobial resistance (AMR) will be published separately later this year. The 2025 GLASS AMR report will expand on previous editions by presenting regional- CTA-level AMR estimates and trends across 93 pathogen-antibiotic combinations from CTAs enrolled by the end of 2024.
100
Esther van Kleef @esthervk.bsky.social · 29/04/2025
The latest Global Antimicrobial Resistance and Use Surveillance System (GLASS) report on antimicrobial use is now out, reporting on 2022 national AMU surveillance data globally tinyurl.com/3muyp2pu @who.int .
260
Esther van Kleef @esthervk.bsky.social · 15/04/2025
Emphasising the relevance of such information is something I feel we should target, among others by working on direct ways (eg good dashboards) of feeding back national and local AMR/isolate data. Until then, we are limited to reporting AMR prevalence.
000
Esther van Kleef @esthervk.bsky.social · 15/04/2025
On another note: WHO GLASS has moved to individual isolate reporting since 2023. This is great and will provide a first possibility to move beyond reporting prevalences only. But countries to date struggle even to report much needed denominators for incidence.
100
Esther van Kleef @esthervk.bsky.social · 15/04/2025
In addition, national surveillance guidance is underway, aiming to inform national action, not global estimates as a stand alone. Discussion are ongoing. For an early version of the survey guidance, see here www.who.int/publications.... Of note: both ACORN I and II and these surveys are intensive.
who.int
GLASS method for estimating attributable mortality of antimicrobial resistant bloodstream infections
Global Antimicrobial Resistance Surveillance System (GLASS)
100
Esther van Kleef @esthervk.bsky.social · 15/04/2025
Good news is that WHO and ACORN collaborators have been working on this in tandem, I.e currently piloted WHO surveys on estimating burden, incl. all indicators presented by ACORN are developed in close consultation with/borrowing from similar protocols for places where MML access is challenging
110